Thank you, Madam Chair.
I'm tempted to ask whether there is at least a national pharmaceutical strategy somewhere at work in the bureaucracy, but maybe we'll come to that another day. Maybe I could suggest you look at Life Before Pharmacare, which was the report by the Canadian Health Coalition, written after they conducted extensive hearings across the country. It documents what happens to workers when they lose their jobs and they don't have access to pharmaceuticals and why this issue is growing in importance today.
Let me just ask three short questions. First, can the organizations dealing with services for HIV and AIDS be guaranteed that they will not receive any more cutbacks this year, since they had a huge cutback last year? Second, further to the Bloc's question and the $12.9 million that was not spent under the tobacco strategy, I'd like to ask where that money went and why it was not used to deal with the tobacco strategy for first nations, to help deal with a serious problem at that level. Thirdly, the CIHR funds were cut in this budget, down from $998 million to $932 million. Is there any chance that could be reconsidered for some of the organizations, like juvenile diabetes, that have been begging this government for some assistance? Would they be able to have access to some of that money?